Stockreport

Twist Bioscience: Ingenious Product Still Lacks Compelling Use Cases [Seeking Alpha]

Twist Bioscience Corporation  (TWST) 
Last twist bioscience corporation earnings: 2/6 04:05 pm Check Earnings Report
PDF TWST targets adjusted EBITDA breakeven in Q4 2026, with gross margin expected above 52% for fiscal 2026. The company's DNA synthesis platform and AI-driven growth are [Read more]